SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-11-036726
Filing Date
2011-06-29
Accepted
2011-06-29 15:37:14
Documents
1
Period of Report
2011-06-28

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c19422_4x0.html 4  
1 MAIN DOCUMENT DESCRIPTION c19422_4x0.xml 4 3760
  Complete submission text file 0001209191-11-036726.txt   5240
Mailing Address 7 WELLS AVENUE STE 34 NEWTON MA 02459
Business Address 7 WELLS AVENUE STE 34 NEWTON MA 02459 617-559-0033
GALECTIN THERAPEUTICS INC (Issuer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AXONYX INC 500 SEVENTH AVE 1OTH FLOOR NEW YORK NY 10018
Business Address
NEILL SYDNEY COLIN (Reporting) CIK: 0001263844 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31791 | Film No.: 11938840